By Rick Holmes
Back in 2004, when Merck took Vioxx off the market, I remember reading that investigators believed the drug may have been responsible for as many as 50,000 deaths from heart attacks and strokes. 50,000! That must be a typo, I remember thinking, because, while the number appeared in various accounts, nobody seemed too upset about it. The story was played on the business pages, with more concern voiced about the hit on Merck’s stock price than on the victims. ...
More in this Category
IG Farben and the Holocaust
Drug Company Penalties are Failing to Curb Illegal Activities
The American Action Network: John Boehner’s Multi-Million Dollar Corporate Bodyguards
Pfizer Employee Claims Company Fired Her After Infection From An Engineered Virus
One Response to “Merck: Vioxx Body Count & Case Study”
This is the right website for anybody who really wants to understand
this topic. You realize so much its almost hard to
argue with you (not that I really would want to HaHa).
You definitely put a brand new spin on a topic which has been written about for ages.
Great stuff, just excellent!